Home » Topics » Regulatory » Patents

Patents
RSS

Achillion discovers complement factor D inhibitors

Sep. 7, 2015

Boehringer Ingelheim discloses neutrophil elastase inhibitors

Sep. 7, 2015

Bionomics presents new VEGFR-3/FAK inhibitors

Sep. 7, 2015

Daiichi Sankyo discloses RuvB-like 1/RuvB-like 2 complex ATPase inhibitors

Sep. 7, 2015

Frost Biologic discloses new antimitotics

Sep. 4, 2015

Bristol-Myers Squibb presents macrocyclic HIV integrase inhibitors

Sep. 4, 2015

Takeda patents OX1 receptor antagonists

Sep. 4, 2015

Bayer presents novel dual sGC activators and PDE5 inhibitors

Sep. 4, 2015

GSK discloses IFN-alpha inducers

Sep. 4, 2015

Incyte patents LSD1 inhibitors

Sep. 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...